EUVIMEDDescoperă EUVIMED
Open access

RNF216 as a Promising Biomarker for Prognosis, Immunotherapy, and Chemotherapy in LIHC: A Comprehensive Pan-Cancer Analysis and Experimental Validation

Ke Du, Xiao Liang, Bowen Qin, Zitao Liu, Nanbin Liu, Pincheng Li, Qian Wang, Yajie Qi, Enze Shi, Kun Li

Journal of Cancer · 2026-01-30 · 17 (3) · 483-506

DOI: 10.7150/jca.125407 ↗

At a glance

Journal article in Journal of Cancer, published on 2026-01-30. Written by Ke Du and 9 co-authors. Institution: National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'…. Cited 1 times so far (Crossref). The full text is freely available in PubMed Central.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Niciun rezumat disponibil.

Subjects

Author keywords

LIHCRNF216chemotherapyimmunotherapyprognosis

Authors and institutions

  • National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Cite

APA

Du, K., Liang, X., Qin, B., Liu, Z., Liu, N., Li, P., Wang, Q., Qi, Y., Shi, E., & Li, K. (2026). RNF216 as a Promising Biomarker for Prognosis, Immunotherapy, and Chemotherapy in LIHC: A Comprehensive Pan-Cancer Analysis and Experimental Validation. Journal of Cancer, 17(3), 483-506. https://doi.org/10.7150/jca.125407

Vancouver

Du K, Liang X, Qin B, Liu Z, Liu N, Li P, et al. RNF216 as a Promising Biomarker for Prognosis, Immunotherapy, and Chemotherapy in LIHC: A Comprehensive Pan-Cancer Analysis and Experimental Validation. Journal of Cancer. 2026;17(3):483-506. doi:10.7150/jca.125407

BibTeX
@article{Du2026,
  author = {Du, Ke and Liang, Xiao and Qin, Bowen and Liu, Zitao and Liu, Nanbin and Li, Pincheng and Wang, Qian and Qi, Yajie and Shi, Enze and Li, Kun},
  title = {RNF216 as a Promising Biomarker for Prognosis, Immunotherapy, and Chemotherapy in LIHC: A Comprehensive Pan-Cancer Analysis and Experimental Validation},
  journal = {Journal of Cancer},
  year = {2026},
  volume = {17},
  number = {3},
  pages = {483--506},
  doi = {10.7150/jca.125407}
}
Start for free →